- Home
- VOR vs CFBK Comparison
VOR vs CFBK Comparison
Compare VOR & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- CFBK
- Stock Information
- Founded
- VOR 2015
- CFBK 1892
- Country
- VOR United States
- CFBK United States
- Employees
- VOR N/A
- CFBK N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- CFBK Major Banks
- Sector
- VOR Health Care
- CFBK Finance
- Exchange
- VOR Nasdaq
- CFBK Nasdaq
- Market Cap
- VOR 85.7M
- CFBK 127.9M
- IPO Year
- VOR 2021
- CFBK 1998
- Fundamental
- Price
- VOR $0.16
- CFBK $23.84
- Analyst Decision
- VOR Strong Buy
- CFBK
- Analyst Count
- VOR 7
- CFBK 0
- Target Price
- VOR $9.43
- CFBK N/A
- AVG Volume (30 Days)
- VOR 943.4K
- CFBK 16.5K
- Earning Date
- VOR 05-16-2025
- CFBK 05-06-2025
- Dividend Yield
- VOR N/A
- CFBK 1.16%
- EPS Growth
- VOR N/A
- CFBK N/A
- EPS
- VOR N/A
- CFBK 2.27
- Revenue
- VOR N/A
- CFBK $47,766,000.00
- Revenue This Year
- VOR N/A
- CFBK N/A
- Revenue Next Year
- VOR N/A
- CFBK N/A
- P/E Ratio
- VOR N/A
- CFBK $10.46
- Revenue Growth
- VOR N/A
- CFBK 1.43
- 52 Week Low
- VOR $0.15
- CFBK $16.92
- 52 Week High
- VOR $1.87
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- VOR 14.74
- CFBK 67.43
- Support Level
- VOR $0.65
- CFBK $23.50
- Resistance Level
- VOR $0.85
- CFBK $24.00
- Average True Range (ATR)
- VOR 0.07
- CFBK 0.48
- MACD
- VOR -0.03
- CFBK 0.22
- Stochastic Oscillator
- VOR 1.88
- CFBK 88.86
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.